Clinical Trial Update: Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer [Phase 2]

View source ↗

Summary

Phase II trial of carboplatin and pemetrexed with or without AZD1775 in previously untreated stage IV non-squamous non-small cell lung cancer was terminated, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AZD1775 (Adavosertib)
• CARBOPLATIN (Carboplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: AstraZeneca | Conditions: Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-03-29